Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 11.30M $181.91M March 31, 2014
T. Rowe Price Associates 10.26M $152.19M June 30, 2014
BVF 5.93M $50.40M Dec. 31, 2011
OrbiMed Advisors 4.68M $69.34M June 30, 2014
Perceptive Advisors 4.60M $68.26M June 30, 2014
BB Biotech AG 3.09M $45.80M June 30, 2014
BlackRock Fund Advisors 2.58M $38.25M June 30, 2014
Vanguard 2.22M $32.87M June 30, 2014
Franklin Resources 2.20M $32.71M June 30, 2014
STATE STREET CORPORATION 2.17M $32.23M June 30, 2014
BlackRock Institutional Trust Company, N.A. 2.08M $30.84M June 30, 2014
S.A.C. Capital Advisors 1.88M $14.07M Dec. 31, 2012
Visium Asset Management 1.78M $26.48M June 30, 2014
Jennison Associates 1.64M $18.59M Sept. 30, 2013
Dr. Jeffrey R. Jay, M.D. 1.51M $22.42M June 30, 2014
Hambrecht & Quist Capital Management 1.48M $11.09M Dec. 31, 2012
Deutsche Bank Aktiengesellschaft 1.39M $15.73M Sept. 30, 2013
Turner Investments 1.27M $14.39M Sept. 30, 2013
VHCP Management 1.27M $14.39M Sept. 30, 2013
Loomis, Sayles and 1.26M $9.98M Sept. 30, 2012
Arrowpoint Asset Management 1.26M $20.23M March 31, 2014

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wellington Management Company June 30, 2011 1.93M $15.56M